Basic Medical Research Training in Oncology

肿瘤学基础医学研究培训

基本信息

  • 批准号:
    8688157
  • 负责人:
  • 金额:
    $ 40.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1987
  • 资助国家:
    美国
  • 起止时间:
    1987-09-05 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The objective of the training program in Basic Medical Research in Oncology at the University of Chicago is to provide an outstanding interdisciplinary research training environment for postdoctoral fellows who have completed a minimum of three years of postgraduate training in internal medicine (including at least one year in hematology/Oncology) in order to prepare them for academic careers in oncology. The Section of Hematology/Oncology offers a three-year ACGME training in hematology/oncology with the expectation that candidates for research training will complete one clinical year funded by the hospital and then have a minimum of two or three years of training under the proposed training grant. The direction of the program -- the integration of training in basic and clinical oncology has not changed since the program's inception but we have significantly enhanced our training in clinical research, cancer genomics, population and health services research in response to a national need. Unique structural elements in the training include: 1) access to a diverse population of cancer patients; 2) training under the guidance of multidisciplinary research preceptor (s) within project areas; 3) specific educational pathways in the form of course work and special seminars leading to a Master of Health Studies degree or Certificate; 4) service learning opportunities to reduce cancer disparities and inequities. The research training faculty preceptors interact on a number of collaborative research and training efforts. This interaction is fostered by the close proximity of the investigators at the University of Chicago campus and particularly by their research activities within our NCI-designated comprehensive cancer center. Generally, research programs fall into three distinct areas - patient-oriented research, translational/basic science and population science research. In the proposed training period, we shall continue the successful elements of the program and enhance the curricular offerings by providing coursework in emerging areas of translational research including bioinformatics, cancer genomics, comparative effectiveness, and global health. Our extensive inpatient and outpatient facilities will continue to promote a comprehensive clinical training experience, while our research laboratories will allow for the acquisition of basic science skills. In addition, our diverse population on the southside of Chicago and our Global partners will provide learning opportunities in community based research locally and at International sites. Physicians completing our training program will enter the oncology work force as socially responsible citizens who are prepared for global leadership in oncology and can advance novel interdisciplinary approaches to solve complex problems in cancer research. With the rapid pace of scientific advances and an aging population prone to cancer, a well trained academic oncology work force as proposed in this training program remains a wise investment for the nation.
描述(由申请人提供):芝加哥大学肿瘤学基础医学研究培训计划的目标是为博士后研究员提供优秀的跨学科研究培训环境,他们已经完成了至少三年的内科研究生培训(包括至少一年的血液学/肿瘤学),以便为他们在肿瘤学的学术生涯做好准备。血液学/肿瘤科提供为期三年的血液学/肿瘤学ACGME培训,期望研究培训的候选人将完成由医院资助的一个临床年,然后根据拟议的培训补助金进行至少两三年的培训。该计划的方向-基础和临床肿瘤学培训的整合自该计划成立以来一直没有改变,但我们已经显着加强了我们在临床研究,癌症基因组学,人口和卫生服务研究方面的培训,以满足国家的需求。培训中独特的结构要素包括:1)接触不同人群的癌症患者; 2)在项目领域内多学科研究导师的指导下进行培训; 3)以课程工作和特殊研讨会的形式提供特定的教育途径,以获得健康研究硕士学位或证书; 4)减少癌症差异和不平等的服务学习机会。研究培训学院的导师在一些合作研究和培训工作中进行互动。这种相互作用 这得益于芝加哥大学校园内研究人员的密切联系,特别是他们在我们的NCI指定的综合癌症中心内的研究活动。一般来说,研究项目分为三个不同的领域-以患者为导向的研究,转化/基础科学和人口科学研究。在拟议的培训期间,我们将继续该计划的成功要素,并通过提供包括生物信息学,癌症基因组学,比较有效性和全球健康在内的新兴转化研究领域的课程来加强课程设置。我们广泛的住院和门诊设施将继续促进全面的临床培训经验,而我们的研究实验室将允许获得基本的科学技能。此外,我们在芝加哥南部的多元化人口和我们的全球合作伙伴将在当地和国际网站提供基于社区的研究学习机会。完成我们的培训计划的医生将作为具有社会责任感的公民进入肿瘤学工作队伍,他们为肿瘤学的全球领导做好了准备,并可以推进新的跨学科方法来解决癌症研究中的复杂问题。随着科学进步的快速发展和人口老龄化倾向于癌症,在这个培训计划中提出的训练有素的学术肿瘤学工作队伍仍然是国家的明智投资。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ezra Cohen其他文献

Ezra Cohen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ezra Cohen', 18)}}的其他基金

Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC
联合靶向 HER3 致癌信号通路和 PD-1 作为 HNSCC 的新型多模式精准免疫疗法
  • 批准号:
    10061585
  • 财政年份:
    2019
  • 资助金额:
    $ 40.91万
  • 项目类别:
Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC
联合靶向 HER3 致癌信号通路和 PD-1 作为 HNSCC 的新型多模式精准免疫疗法
  • 批准号:
    10304190
  • 财政年份:
    2019
  • 资助金额:
    $ 40.91万
  • 项目类别:
Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC
联合靶向 HER3 致癌信号通路和 PD-1 作为 HNSCC 的新型多模式精准免疫疗法
  • 批准号:
    9917561
  • 财政年份:
    2019
  • 资助金额:
    $ 40.91万
  • 项目类别:
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC
HNSCC 中巨噬细胞 PI3Kgamma 的治疗靶向
  • 批准号:
    9899741
  • 财政年份:
    2018
  • 资助金额:
    $ 40.91万
  • 项目类别:
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
寻找针对可识别致癌状态的药物和免疫疗法组合的合理系统方法
  • 批准号:
    9363695
  • 财政年份:
    2017
  • 资助金额:
    $ 40.91万
  • 项目类别:
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
寻找针对可识别致癌状态的药物和免疫疗法组合的合理系统方法
  • 批准号:
    10004824
  • 财政年份:
    2017
  • 资助金额:
    $ 40.91万
  • 项目类别:
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
寻找针对可识别致癌状态的药物和免疫疗法组合的合理系统方法
  • 批准号:
    10226232
  • 财政年份:
    2017
  • 资助金额:
    $ 40.91万
  • 项目类别:
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
寻找针对可识别致癌状态的药物和免疫疗法组合的合理系统方法
  • 批准号:
    9751822
  • 财政年份:
    2017
  • 资助金额:
    $ 40.91万
  • 项目类别:
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
寻找针对可识别致癌状态的药物和免疫疗法组合的合理系统方法
  • 批准号:
    10016089
  • 财政年份:
    2017
  • 资助金额:
    $ 40.91万
  • 项目类别:
Maximizing Efficacy of EGFR Inhibitors by Defining Resistance Mechanisms
通过定义耐药机制最大化 EGFR 抑制剂的功效
  • 批准号:
    8530212
  • 财政年份:
    2012
  • 资助金额:
    $ 40.91万
  • 项目类别:

相似海外基金

Basic Medical Research Training in Oncology
肿瘤学基础医学研究培训
  • 批准号:
    10197779
  • 财政年份:
    1987
  • 资助金额:
    $ 40.91万
  • 项目类别:
Basic Medical Research Training in Oncology
肿瘤学基础医学研究培训
  • 批准号:
    8548235
  • 财政年份:
    1987
  • 资助金额:
    $ 40.91万
  • 项目类别:
Basic Medical Research Training in Oncology
肿瘤学基础医学研究培训
  • 批准号:
    10452572
  • 财政年份:
    1987
  • 资助金额:
    $ 40.91万
  • 项目类别:
Basic Medical Research Training in Oncology
肿瘤学基础医学研究培训
  • 批准号:
    9120808
  • 财政年份:
    1987
  • 资助金额:
    $ 40.91万
  • 项目类别:
Basic Medical Research Training in Medical Oncology
肿瘤内科基础医学研究培训
  • 批准号:
    6645384
  • 财政年份:
    1987
  • 资助金额:
    $ 40.91万
  • 项目类别:
Basic Medical Research Training in Medical Oncology
肿瘤内科基础医学研究培训
  • 批准号:
    7086905
  • 财政年份:
    1987
  • 资助金额:
    $ 40.91万
  • 项目类别:
Basic Medical Research Training in Medical Oncology
肿瘤内科基础医学研究培训
  • 批准号:
    6771155
  • 财政年份:
    1987
  • 资助金额:
    $ 40.91万
  • 项目类别:
Basic Medical Research Training in Medical Oncology
肿瘤内科基础医学研究培训
  • 批准号:
    6500024
  • 财政年份:
    1987
  • 资助金额:
    $ 40.91万
  • 项目类别:
Basic Medical Research Training in Oncology
肿瘤学基础医学研究培训
  • 批准号:
    9977969
  • 财政年份:
    1987
  • 资助金额:
    $ 40.91万
  • 项目类别:
Basic Medical Research Training in Oncology
肿瘤学基础医学研究培训
  • 批准号:
    8899337
  • 财政年份:
    1987
  • 资助金额:
    $ 40.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了